Protocol Ledger

NCT04430790 · Phase III · RECRUITING

Doxapram Therapy in Preterm Infants (DOXA Trial)

Interventional Phase III clinical trial protocol NCT04430790 sponsored by Erasmus Medical Center in Rare Genetic, Women's Health, and Other, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2020-06-15 Enrollment: 396 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT04430790
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)396 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)0 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT04430790
Protocol FieldVerified Registry Value
NCT IdentifierNCT04430790
Consolidated Lead SponsorErasmus Medical Center
Therapeutic Condition CohortRare Genetic, Women's Health, and Other
Clinical Trial PhasePhase III
Overall Recruitment StatusRECRUITING
Registered Enrollment396 participants (ESTIMATED)
Registered Start Date2020-06-15
WhyStopped ClassificationNot Stopped

Search related sites and sponsors in the Interactive Directory, explore Rare Genetic, Women's Health, and Other Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI